{"id":"https://openalex.org/W7219772222","doi":"https://doi.org/10.3389/fimmu.2026.1923404","title":"Soluble TIM-3 and galectin-9 in cerebrospinal fluid are associated with disability at 6 months in aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder","display_name":"Soluble TIM-3 and galectin-9 in cerebrospinal fluid are associated with disability at 6 months in aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder","publication_year":2026,"publication_date":"2026-10-05","ids":{"openalex":"https://openalex.org/W7219772222","doi":"https://doi.org/10.3389/fimmu.2026.1923404","pmid":"https://pubmed.ncbi.nlm.nih.gov/42898123","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13677341"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1923404","doi":"https://doi.org/10.3389/fimmu.2026.1923404","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1923404","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1923404/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1923404/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023304883","display_name":"Shota Nishii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I65837984","display_name":"Kobe University","ror":"https://ror.org/03tgsfw79","country_code":"JP","type":"education","lineage":["https://openalex.org/I65837984"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shota Nishii","raw_affiliation_strings":["Division of Neurology, Kobe University Graduate School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurology, Kobe University Graduate School of Medicine","institution_ids":["https://openalex.org/I65837984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022909568","display_name":"Ritsu Akatani","orcid":"https://orcid.org/0000-0003-3982-1108","observed_orcids":["https://orcid.org/0000-0003-3982-1108"]},"institutions":[{"id":"https://openalex.org/I65837984","display_name":"Kobe University","ror":"https://ror.org/03tgsfw79","country_code":"JP","type":"education","lineage":["https://openalex.org/I65837984"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ritsu Akatani","raw_affiliation_strings":["Division of Neurology, Kobe University Graduate School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurology, Kobe University Graduate School of Medicine","institution_ids":["https://openalex.org/I65837984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058496522","display_name":"Kyoka Shiroma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I65837984","display_name":"Kobe University","ror":"https://ror.org/03tgsfw79","country_code":"JP","type":"education","lineage":["https://openalex.org/I65837984"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kyoka Shiroma","raw_affiliation_strings":["Division of Neurology, Kobe University Graduate School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurology, Kobe University Graduate School of Medicine","institution_ids":["https://openalex.org/I65837984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083154378","display_name":"\u4eae\u7950 \u7af9\u7530","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I65837984","display_name":"Kobe University","ror":"https://ror.org/03tgsfw79","country_code":"JP","type":"education","lineage":["https://openalex.org/I65837984"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryosuke Takeda","raw_affiliation_strings":["Division of Neurology, Kobe University Graduate School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurology, Kobe University Graduate School of Medicine","institution_ids":["https://openalex.org/I65837984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080775766","display_name":"Asato Tsuji","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I65837984","display_name":"Kobe University","ror":"https://ror.org/03tgsfw79","country_code":"JP","type":"education","lineage":["https://openalex.org/I65837984"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Asato Tsuji","raw_affiliation_strings":["Division of Neurology, Kobe University Graduate School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurology, Kobe University Graduate School of Medicine","institution_ids":["https://openalex.org/I65837984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089810174","display_name":"Kimitaka Katanazaka","orcid":"https://orcid.org/0009-0008-7000-0221","observed_orcids":["https://orcid.org/0009-0008-7000-0221"]},"institutions":[{"id":"https://openalex.org/I65837984","display_name":"Kobe University","ror":"https://ror.org/03tgsfw79","country_code":"JP","type":"education","lineage":["https://openalex.org/I65837984"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kimitaka Katanazaka","raw_affiliation_strings":["Division of Neurology, Kobe University Graduate School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurology, Kobe University Graduate School of Medicine","institution_ids":["https://openalex.org/I65837984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046307365","display_name":"Shusuke Koto","orcid":"https://orcid.org/0000-0003-3892-4500","observed_orcids":["https://orcid.org/0000-0003-3892-4500"]},"institutions":[{"id":"https://openalex.org/I65837984","display_name":"Kobe University","ror":"https://ror.org/03tgsfw79","country_code":"JP","type":"education","lineage":["https://openalex.org/I65837984"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shusuke Koto","raw_affiliation_strings":["Division of Neurology, Kobe University Graduate School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurology, Kobe University Graduate School of Medicine","institution_ids":["https://openalex.org/I65837984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070845460","display_name":"Norio Chihara","orcid":"https://orcid.org/0000-0003-4499-0790","observed_orcids":["https://orcid.org/0000-0003-4499-0790"]},"institutions":[{"id":"https://openalex.org/I65837984","display_name":"Kobe University","ror":"https://ror.org/03tgsfw79","country_code":"JP","type":"education","lineage":["https://openalex.org/I65837984"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Norio Chihara","raw_affiliation_strings":["Division of Neurology, Kobe University Graduate School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurology, Kobe University Graduate School of Medicine","institution_ids":["https://openalex.org/I65837984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5070845460"],"corresponding_institution_ids":["https://openalex.org/I65837984"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.73629044,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1923404","last_page":"1923404"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuromyelitis-optica-spectrum-disorder","display_name":"neuromyelitis optica spectrum disorder","score":0.9660000205039978},{"id":"https://openalex.org/keywords/aquaporin-4-antibodies","display_name":"aquaporin-4 antibodies","score":0.8550000190734863},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-biomarkers","display_name":"cerebrospinal fluid biomarkers","score":0.8849999904632568},{"id":"https://openalex.org/keywords/tim-3","display_name":"TIM-3","score":0.7450000047683716},{"id":"https://openalex.org/keywords/galectin-9","display_name":"galectin-9","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-proteins","display_name":"immune checkpoint molecules","score":0.7269999980926514},{"id":"https://openalex.org/keywords/disability-outcome","display_name":"disability outcome","score":0.5130000114440918},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7450000047683716},{"id":"https://openalex.org/keywords/myelin-oligodendrocyte-glycoprotein-antibody-associated-disease","display_name":"myelin oligodendrocyte glycoprotein antibody-associated disease","score":0.921999990940094},{"id":"https://openalex.org/keywords/idiopathic-normal-pressure-hydrocephalus","display_name":"idiopathic normal pressure hydrocephalus","score":0.875},{"id":"https://openalex.org/keywords/il-2-receptor-alpha","display_name":"IL-2 receptor alpha","score":0.8029999732971191},{"id":"https://openalex.org/keywords/acute-relapse","display_name":"acute relapse","score":0.6019999980926514}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8485999703407288},{"id":"https://openalex.org/C2781137167","wikidata":"https://www.wikidata.org/wiki/Q611458","display_name":"Neuromyelitis optica","level":3,"score":0.8379999995231628},{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.8062999844551086},{"id":"https://openalex.org/C2779357208","wikidata":"https://www.wikidata.org/wiki/Q6947292","display_name":"Myelin oligodendrocyte glycoprotein","level":4,"score":0.6215999722480774},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.5181000232696533},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.5135999917984009},{"id":"https://openalex.org/C2777154362","wikidata":"https://www.wikidata.org/wiki/Q7575316","display_name":"Spectrum disorder","level":2,"score":0.477400004863739},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4187999963760376},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4165000021457672},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3978999853134155},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3788999915122986},{"id":"https://openalex.org/C2776985911","wikidata":"https://www.wikidata.org/wiki/Q916698","display_name":"Oligodendrocyte","level":4,"score":0.36809998750686646},{"id":"https://openalex.org/C58471807","wikidata":"https://www.wikidata.org/wiki/Q327120","display_name":"Receiver operating characteristic","level":2,"score":0.35830000042915344},{"id":"https://openalex.org/C10162356","wikidata":"https://www.wikidata.org/wiki/Q1135939","display_name":"Pathophysiology","level":2,"score":0.3564000129699707},{"id":"https://openalex.org/C2776572573","wikidata":"https://www.wikidata.org/wiki/Q972514","display_name":"Optic neuritis","level":3,"score":0.3474999964237213},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.33709999918937683},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.33640000224113464},{"id":"https://openalex.org/C2908708501","wikidata":"https://www.wikidata.org/wiki/Q1186703","display_name":"Demyelinating Disorder","level":3,"score":0.3319999873638153},{"id":"https://openalex.org/C2778134817","wikidata":"https://www.wikidata.org/wiki/Q193003","display_name":"Hydrocephalus","level":2,"score":0.3264000117778778},{"id":"https://openalex.org/C146304588","wikidata":"https://www.wikidata.org/wiki/Q961652","display_name":"Case-control study","level":2,"score":0.3197000026702881},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3172000050544739},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.3089999854564667},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3046000003814697},{"id":"https://openalex.org/C2777704947","wikidata":"https://www.wikidata.org/wiki/Q551085","display_name":"Myelitis","level":3,"score":0.30250000953674316},{"id":"https://openalex.org/C2778609137","wikidata":"https://www.wikidata.org/wiki/Q105790271","display_name":"Myelin","level":3,"score":0.2851000130176544}],"mesh":[{"descriptor_ui":"D000072597","descriptor_name":"Hepatitis A Virus Cellular Receptor 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000098542","descriptor_name":"Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009471","descriptor_name":"Neuromyelitis Optica","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D009471","descriptor_name":"Neuromyelitis Optica","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D009471","descriptor_name":"Neuromyelitis Optica","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D037161","descriptor_name":"Galectins","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D051401","descriptor_name":"Aquaporin 4","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.3389/fimmu.2026.1923404","doi":"https://doi.org/10.3389/fimmu.2026.1923404","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1923404","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1923404/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13677341","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13677341/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13677341/pdf/fimmu-17-1923404.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:42898123","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42898123","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:irdb.nii.ac.jp:01257:0007558600","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/20.500.14094/0100505758","pdf_url":"https://da.lib.kobe-u.ac.jp/da/kernel/0100505758/0100505758.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology","raw_type":"journal article"},{"id":"pmh:oai:doaj.org/article:5fce1c9ce95e45f1b355de289c737f37","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5fce1c9ce95e45f1b355de289c737f37","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1923404","doi":"https://doi.org/10.3389/fimmu.2026.1923404","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1923404","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1923404/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G8344538381","display_name":"Development of an inflammatory environment model in the brain that recapitulates the neurodegenerative process of immune-related neurological diseases","funder_award_id":"23K27488","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320311405","display_name":"Japan Agency for Medical Research and Development","ror":"https://ror.org/004rtk039"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7219772222.pdf","grobid_xml":"https://content.openalex.org/works/W7219772222.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W2013177587","https://openalex.org/W2046473753","https://openalex.org/W2070631889","https://openalex.org/W2093368037","https://openalex.org/W2112165124","https://openalex.org/W2129229339","https://openalex.org/W2955624357","https://openalex.org/W3122065698","https://openalex.org/W3127273054","https://openalex.org/W4318391603","https://openalex.org/W4320857284","https://openalex.org/W4385618224","https://openalex.org/W4387676029","https://openalex.org/W4389509002","https://openalex.org/W4391069576","https://openalex.org/W4391773766","https://openalex.org/W4393029200","https://openalex.org/W4395069240","https://openalex.org/W4403901072","https://openalex.org/W7148313727"],"related_works":["https://openalex.org/W3158003996","https://openalex.org/W4411790053","https://openalex.org/W7168127398","https://openalex.org/W2081485321","https://openalex.org/W4361001100","https://openalex.org/W2117525719","https://openalex.org/W4412879918","https://openalex.org/W4414920420","https://openalex.org/W7205451122","https://openalex.org/W2955735927"],"abstract_inverted_index":{"Background:":[0],"Neuromyelitis":[1],"optica":[2],"spectrum":[3],"disorders":[4],"(NMOSD)":[5],"are":[6,51],"severe":[7,164,188,203,235],"autoimmune":[8],"diseases":[9],"of":[10,25,32,70,123,179,192,225,248,261],"the":[11,23,38,66,148,199,202,234,244,269],"central":[12],"nervous":[13],"system":[14],"characterized":[15],"by":[16],"autoantibodies":[17],"against":[18],"aquaporin":[19],"4":[20],"(AQP4-IgG).":[21],"Despite":[22],"availability":[24],"several":[26],"molecular":[27],"targeted":[28],"therapies,":[29],"biomarkers":[30],"capable":[31],"predicting":[33],"subsequent":[34],"disability":[35,77,276],"early":[36,287],"during":[37,268],"acute":[39,270],"relapse":[40],"phase":[41,272],"remain":[42],"insufficient.":[43],"Given":[44],"that":[45],"abnormalities":[46],"in":[47,56,65,141,147,233,266,293],"immune":[48,62,124],"checkpoint":[49,125],"molecules":[50,64,126,144],"known":[52],"to":[53,120,172,198],"be":[54],"involved":[55],"autoimmunity,":[57],"this":[58],"study":[59],"investigated":[60],"whether":[61],"checkpoint-related":[63],"cerebrospinal":[67,214],"fluid":[68,215,223],"(CSF)":[69],"acute-phase":[71],"AQP4-IgG-positive":[72,256],"NMOSD":[73,180,257],"patients":[74,83,89,101],"correlate":[75,273],"with":[76,84,90,102,241,274],"at":[78,153,278],"6":[79,154,279],"months.":[80,280],"Methods:":[81],"Thirty-four":[82],"AQP4":[85],"IgG-positive":[86],"NMOSD,":[87],"10":[88],"myelin":[91],"oligodendrocyte":[92],"glycoprotein":[93],"antibody-associated":[94],"disease":[95,97,112],"(MOGAD)at":[96],"flare,":[98],"and":[99,127,184,212,228,251,264],"11":[100],"idiopathic":[103],"normal":[104],"pressure":[105],"hydrocephalus":[106],"(iNPH)":[107],"as":[108,158,286],"control":[109],"non-inflammatory":[110],"neurological":[111],"were":[113,118,145,230],"enrolled.":[114],"Bead-based":[115],"multiplex":[116],"assays":[117],"used":[119],"quantify":[121],"levels":[122,217,224,260],"related":[128],"factors":[129],"(PD-1,":[130],"PD-L1,":[131],"CTLA-4,":[132],"TIM-3,":[133,226,262],"galectin-9,":[134,227,263],"LAG-3,":[135],"4-1BB,":[136],"B7.2,":[137],"IL-2R\u03b1,":[138],"TGF-\u03b21,":[139],"FasL)":[140],"CSF.":[142],"These":[143,281],"measured":[146],"soluble":[149],"fraction.":[150],"Disease":[151],"severity":[152,277],"months":[155],"was":[156,170],"classified":[157],"mild":[159,182,195,200],"(EDSS":[160,165],"<":[161],"6)":[162],"or":[163],"\u2265":[166],"6).":[167],"ROC":[168,245],"analysis":[169],"performed":[171],"evaluate":[173],"prognostic":[174,288],"performance.":[175],"Results:":[176],"Twenty-six":[177],"cases":[178,186,191],"showed":[181,187,194],"disability,":[183],"8":[185],"disability.":[189,196],"All":[190],"MOGAD":[193],"Compared":[197],"group,":[201],"group":[204,236],"had":[205],"higher":[206,209,213,232],"age,":[207],"a":[208,294],"male":[210],"ratio,":[211],"protein":[216],"(p=0.004,":[218],"p=0.017,":[219],"p<0.001,":[220],"respectively).":[221],"Cerebrospinal":[222],"IL-2R\u03b1":[229,265],"significantly":[231],"(p=0.011,":[237],"p=0.008,":[238],"p=0.006,":[239],"respectively),":[240],"area":[242],"under":[243],"curve":[246],"values":[247],"0.89,":[249],"0.88,":[250],"0.80,":[252],"respectively.":[253],"Conclusion:":[254],"In":[255],"patients,":[258],"elevated":[259],"CSF":[267],"attack":[271],"worsening":[275],"findings":[282],"suggest":[283],"their":[284],"potential":[285],"biomarkers,":[289],"which":[290],"requires":[291],"validation":[292],"large":[295],"cohort.":[296]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-10-05T00:00:00"}